Oric Pharmaceuticals, Inc. ORIC Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s change in AP?
- Oric Pharmaceuticals, Inc. (ORIC) reported change in AP of -$3.32M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Oric Pharmaceuticals, Inc.'s change in AP increased by 58.0% year-over-year, from -$7.91M to -$3.32M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.